Current share price for TRJ : $0.265 0.015 (6%)+
Trajan Group Holdings Limited (TRJ), an ASX-listed company, is a global developer and manufacturer of analytical and life sciences products and devices founded to enable science that benefits people by enriching personal health through scientific tools and solutions. These products and solutions are used in the analysis of biological, food, and environmental samples. Trajan has a portfolio and pipeline of new technologies which support the move towards decentralised, personalised data-based healthcare.
| ASX Code | TRJ |
| Website | http://www.trajanscimed.com |
| Industry/Sector | Life Sciences Tools & Services |
| Market Cap ($M) | 40 |
| TRJ Share Price | $0.265 |
| Day High | $0.270 |
| Day Low | $0.250 |
| Last Close | $0.250 |
| TRJ Share Price Movement | $0.02 ( 6% ) |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Trajan Group Holdings Limited (TRJ) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$2.76 | -$1.80 | -159.70% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | $4.61 | $3.00 | 35.30% | 41.40 | 0.00 | 0.00% | 0.0% |
| 2023A | $3.41 | $2.20 | -35.80% | 82.90 | 0.00 | 0.00% | 0.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Trajan Group Holdings Limited (TRJ) | $38M | -1.5974 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 3.00 | 0.00 | 0.38 | 0.00 |
| Market | 0.29 | 13.20 | 1.17 | 0.67 |
| Sector | 0.43 | 26.00 | 2.55 | 2.41 |
| Name | Position | Start Date |
|---|---|---|
| Mr Robert (Bob) John Lyon | Head of Corporate Development and General Counsel, Executive Director | 3 Sep 2014 |
| Mr Stephen Andrew Tomisich | Chief Executive Officer, Managing Director | 11 Aug 2011 |
| Mr John Anthony Eales | Non-Executive Chairman, Non-Executive Director | 23 Mar 2021 |
| Mr Rohit Khanna | Non-Executive Director | 23 Mar 2021 |
| Ms Tiffiny Jane Lewin | Non-Executive Director | 23 Mar 2021 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 31 Mar 2026 | LEWIN, Tiffiny | Buy | Direct Shares | 17,721 | $0.400 | $7,088.400 |
| 26 Nov 2025 | TOMISICH, Stephen | Buy | Indirect Shares | 13,569 | $0.650 | $8,819.850 |
| 25 Nov 2025 | TOMISICH, Stephen | Buy | Indirect Shares | 24,055 | $0.650 | $15,631.920 |
See all changes in directors' interest & trades for Trajan Group Holdings Limited (TRJ) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| Simon Billingham | Chief Financial Officer,Interim Joint Company Secretary |
| Alister John Hodges | Chief Financial Officer,Joint Company Secretary |
| Mark Andrew Licciardo | Joint Company Secretary |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Trajan Group Holdings Limited (TRJ). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 76,470,588 (51.17%) | Tomisich Family Pty Ltd |
| 14,520,963 (9.53%) | MA Financial Group Limited |
| 11,209,603 (7.36%) | Investors Mutual Limited |
| 9,958,728 (6.55%) | Australiansuper Pty Ltd |
| Date | Event |
|---|---|
| 25 February 2027 | Report (Interim) |
| 27 August 2026 | Report (Annual) |
| 27 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.